Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral influenza vaccine for early colorectal cancer
2020-000725-27Phase 2Terminated
- Sponsor
- Center for Surgical Science, Department of Surgery, Zealand University Hospital
- Start
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of influenza vaccine in colorectal cancer (CRC), sponsored by Center for Surgical Science, Department of Surgery, Zealand University Hospital. Primary endpoint: Safety endpoints. Started Apr 2020; status: terminated.
02
Drugs
influenza vaccine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2020-000725-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000725-27.